Biomarkers for immunotherapy of hepatocellular carcinoma
National Cancer Institute · Icahn School of Medicine at Mount Sinai · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
194
total citations
- FWCI
- 42.04
- Percentile
- 100%
- References
- 225
Citations per year
Authors
8- TFTim F. GretenCorresponding
National Cancer Institute
- AVAugusto Villanueva
Icahn School of Medicine at Mount Sinai
- FKFirouzeh Korangy
National Cancer Institute, Center for Cancer Research
- BRBenjamin Ruf
National Cancer Institute, Center for Cancer Research
- MYMark Yarchoan
Bloomberg (United States), Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Topics & keywords
Topics
Keywords
- Medicine
- Durvalumab
- Atezolizumab
- Sorafenib
- Biomarker
- Immunotherapy
- Oncology
- Hepatocellular carcinoma
No related works found for this paper.